Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru

被引:3
|
作者
Justo Arevalo, Santiago [1 ,2 ,3 ]
Uribe Calampa, Carmen Sofia [1 ]
Jimenez Silva, Cinthy [4 ]
Quinones Aguilar, Mauro [1 ]
Bouckaert, Remco [5 ]
Rebello Pinho, Joao Renato [2 ,6 ]
机构
[1] Univ Ricardo Palma, Fac Ciencias Biol, Lima, Peru
[2] Hosp Israelita Albert Einstein, Lab Clin, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[4] Univ Auckland, Sch Biol Sci, Auckland, New Zealand
[5] Univ Auckland, Sch Comp Sci, Auckland, New Zealand
[6] Univ Sao Paulo, Dept Gastroenterol & Pathol, LIM03 07, Sch Med, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
SEROPREVALENCE; VACCINATION; MORTALITY; DYNAMICS; IQUITOS; LINEAGE;
D O I
10.1038/s41467-023-39216-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
At over 0.6% of the population, Peru has one of the highest SARS-CoV-2 mortality rate in the world. Much effort to sequence genomes has been done in this country since mid-2020. However, an adequate analysis of the dynamics of the variants of concern and interest (VOCIs) is missing. We investigated the dynamics of the COVID-19 pandemic in Peru with a focus on the second wave, which had the greatest case fatality rate. The second wave in Peru was dominated by Lambda and Gamma. Analysis of the origin of Lambda shows that it most likely emerged in Peru before the second wave (June-November, 2020). After its emergence it reached Argentina and Chile from Peru where it was locally transmitted. During the second wave in Peru, we identify the coexistence of two Lambda and three Gamma sublineages. Lambda sublineages emerged in the center of Peru whereas the Gamma sublineages more likely originated in the north-east and mid-east. Importantly, it is observed that the center of Peru played a prominent role in transmitting SARS-CoV-2 to other regions within Peru.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] SARS-CoV-2 and the pandemic of COVID-19
    Adil, Md Tanveer
    Rahman, Rumana
    Whitelaw, Douglas
    Jain, Vigyan
    Al-Taan, Omer
    Rashid, Farhan
    Munasinghe, Aruna
    Jambulingam, Periyathambi
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116
  • [22] Characteristics of SARS-CoV-2 and COVID-19
    Ben Hu
    Hua Guo
    Peng Zhou
    Zheng-Li Shi
    [J]. Nature Reviews Microbiology, 2021, 19 : 141 - 154
  • [23] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    [J]. REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
  • [24] Delirium and SARS-CoV-2/COVID-19
    von Arnim, C.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [25] SARS-CoV-2, COVID-19, and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 629 - 630
  • [26] Characteristics of SARS-CoV-2 and COVID-19
    Hu, Ben
    Guo, Hua
    Zhou, Peng
    Shi, Zheng-Li
    [J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 141 - 154
  • [27] Dementia and SARS-Cov-2/COVID-19
    Zieschang, T.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [28] SARS-CoV-2 (COVID-19) by the numbers
    Bar-On, Yinon M.
    Flamholz, Avi
    Phillips, Rob
    Milo, Ron
    [J]. ELIFE, 2020, 9
  • [29] SARS-CoV-2, COVID-19 and Neurodegeneration
    Toenges, Lars
    Klebe, Stephan
    [J]. BRAIN SCIENCES, 2022, 12 (07)
  • [30] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01): : 70 - 80